The Role of Galectin-3 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis

The Role of Galectin-3 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is a chronic autoimmune disease that primarily affects small joints, leading to joint inflammation, pain, and limited mobility. New biomarkers specific to RA could facilitate early diagnosis and treatment, while also enabling better monitoring of disease activity and treatm...

Full description

Bibliographic Details
Main Authors:	Shihab Mahmood Almurshedi, Raad Abdulameer Alasady Alasady, Hashim Ali Alsherees, Ali M. Almohana, Kareem Gali Aljayashi, Dhifaf Hameed Almudhaffer
Format:	Article
Language:	Indonesian
Published:	Universitas Islam Negeri Raden Fatah Palembang 2023-08-01
Series:	Jurnal Biota
Subjects:	rheumatoid arthritis, galectin-3, cdai, das-28 esr, and das-28 crp
Online Access:	http://jurnal.radenfatah.ac.id/index.php/biota/article/view/18343

Similar Items

The Role of Interleukin-22 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis
by: Shihab Almurshedi, et al.
Published: (2023-06-01)

ASSESSMENT OF RHEUMATOID ARTHRITIS ACTIVITY DURING PREGNANCY AND POSTPARTUM
by: E. V. Matyanova, et al.
Published: (2015-04-01)

Implication and utility of DAS-28 squeeze in rheumatoid arthritis: an Indian experience
by: H. Singh, et al.
Published: (2022-09-01)

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs
by: Vladimira Boyadzhieva, et al.
Published: (2018-11-01)

Relationship between vitamin D3 level and rheumatoid arthritis patients attending Rizgary Teaching Hospital in Erbil city
by: Banaz Abdulsattar Hamad, et al.
Published: (2017-08-01)

Fibromyalgia as a Modifying Factor of Clinical Course of Rheumatoid Arthritis
by: Perebetyuk L.
Published: (2015-09-01)

Frequency of Thyroid Disorders in Rheumatoid Arthritis Patients and its Association with Disease Activity: A Hospital Based Study
by: Safina Hameed Qureshi, et al.
Published: (2023-06-01)

A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis
by: Kirsten Janke, et al.
Published: (2022-12-01)

Characteristics of Anemia in Rheumatoid Arthritis
by: Anca BOBIRCA, et al.
Published: (2022-09-01)

Hematological markers and ultrasound 7-joint inflammation score as add-on tools in the assessment of inflammation in rheumatoid arthritis patients
by: Abd Elatif Ahmed Gaballah, et al.
Published: (2022-05-01)

Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice
by: D. A. Kusevich, et al.
Published: (2019-01-01)

Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort study
by: Takahiro Nishino, et al.
Published: (2023-03-01)

The role of timely rheumatoid arthritis treatment effectiveness control
by: Larisa M. Musaeva, et al.
Published: (2023-11-01)

Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?
by: K. El-Hadidi, et al.
Published: (2020-01-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
by: Anna Olegovna Pchelintseva, et al.
Published: (2014-02-01)

Factor reumatoide: asociación con la erosión radiológica y actividad de la artritis reumatoide Rheumatoid factor: association with the radiological erosion and with the rheumatoid arthritis activity
by: Elena Kokuina, et al.
Published: (2008-09-01)

Effect of vascular endothelial growth factor gene polymorphisms on disease activity in rheumatoid arthritis
by: Rehab A. Sallam, et al.
Published: (2021-12-01)

Serum matrix metalloproteinase-3 levels monitor the therapeutic efficacy in Syrian patients with rheumatoid arthritis
by: Rama Hussein, et al.
Published: (2023-03-01)

CD28− Cells Are Increased in Early Rheumatoid Arthritis and Are Linked With Cytomegalovirus Status
by: Charlotte Thompson, et al.
Published: (2020-05-01)

Efficacy and Safety of Metformin Use in Rheumatoid Arthritis: A Randomized Controlled Study
by: Mahmoud Gharib, et al.
Published: (2021-09-01)

A study of the association between Galectin-9 gene (LGALS9) polymorphisms and rheumatoid arthritis in Egyptian patients
by: Seham Gouda Ameen, et al.
Published: (2023-07-01)

Analysis of peripheral blood parameters for the diagnosis of inflammatory activity in rheumatoid arthritis
by: V. Muravyov, et al.
Published: (2022-03-01)

Association of positive psychological variables with disease activity, functional disability and erythrocyte sedimentation rate in patients with rheumatoid arthritis: a preliminary study
by: K.C. Meléndez-Monreal, et al.
Published: (2023-03-01)

Galectin-3 and its correlation with carotid ultrasound in rheumatoid arthritis patients
by: Arwa S. Amer, et al.
Published: (2023-12-01)

Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis
by: Yuji Nozaki, et al.
Published: (2021-04-01)

IMPACT OF PREGNANCY ON THE ACTIVITY OF RHEUMATOID ARTHRITIS AND ITS THERAPY ACCORDING TO PROSPECTIVE FOLLOW-UP DATA
by: E. V. Matyanova, et al.
Published: (2015-09-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

DAS28 score vs. ultrasound examination for assessment of rheumatoid arthritis disease activity: comparison and discussion of pros and cons
by: Tacjana Anna Barczyńska, et al.
Published: (2015-09-01)

Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials
by: Josefine Nelson, et al.
Published: (2020-09-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity
by: Benjamin Hur, et al.
Published: (2021-06-01)

Depressão, ansiedade e atividade de doença na artrite reumatóide Depression, anxiety and disease activity in rheumatoid arthritis
by: Antonio Filpi Coimbra da Costa, et al.
Published: (2008-02-01)

The Use of Tocilizumab in Combination with Methotrexate in Indonesian Rheumatoid Arthritis Patients (PICTURE INA Study)
by: Bambang Setyohadi, et al.
Published: (2018-06-01)

The Association of Anti-CCP and Disease Activity in Rheumatoid Arthritis
by: Raouf Rahim Merza, et al.
Published: (2014-08-01)

Serum Calprotectin in Rheumatoid Arthritis: A Promising Diagnostic Marker, How Far Is It Related to Activity and Sonographic Findings?
by: H.E. Mansour, et al.
Published: (2017-03-01)

Dynamics of circulating follicular helper T cell subsets and follicular regulatory T cells in rheumatoid arthritis patients according to HLA-DRB1 locus
by: Paola V. Ferrero, et al.
Published: (2022-12-01)

SERUM FETUIN-A LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Papichev, et al.
Published: (2019-09-01)

Multi-omics profiling reveals potential alterations in rheumatoid arthritis with different disease activity levels
by: Jianghua Chen, et al.
Published: (2023-05-01)